Hmdb loader

HMDBP00272 (Catechol O-methyltransferase) Metabolite Associations

Displaying metabolite protein links 1 - 25 of 94 in total
HMDB ID Name CAS NumberStructureFormula Average Mass
Monoisotopic Mass 		References
HMDB0030609Xanthochymuside31654-49-6ThumbC36H32O16720.6297
720.169034976		Not Available
HMDB0001490Vanylglycol534-82-7ThumbC9H12O4184.1892
184.073558872		Not Available
HMDB0000291Vanillylmandelic acid13244-77-4ThumbC9H10O5198.1727
198.05282343		Not Available
HMDB0014468Tolcapone134308-13-7ThumbC14H11NO5273.2408
273.063722467
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Ries V, Selzer R, Eichhorn T, Oertel WH, Eggert K: Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study. Clin Neuropharmacol. 2010 May;33(3):142-50. doi: 10.1097/WNF.0b013e3181d99d6f. [PubMed:20502133 ]
  3. Guay DR: Tolcapone, a selective catechol-O-methyltransferase inhibitor for treatment of Parkinson's disease. Pharmacotherapy. 1999 Jan;19(1):6-20. [PubMed:9917075 ]
  4. Keating GM, Lyseng-Williamson KA: Tolcapone: a review of its use in the management of Parkinson's disease. CNS Drugs. 2005;19(2):165-84. [PubMed:15697329 ]
  5. Truong DD: Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease. Clin Interv Aging. 2009;4:109-13. Epub 2009 May 14. [PubMed:19503773 ]
  6. Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR: Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology. 2007 May;32(5):1011-20. Epub 2006 Oct 25. [PubMed:17063156 ]
  7. Stocchi F, De Pandis MF: Utility of tolcapone in fluctuating Parkinson's disease. Clin Interv Aging. 2006;1(4):317-25. [PubMed:18046910 ]
  8. Forsberg M, Lehtonen M, Heikkinen M, Savolainen J, Jarvinen T, Mannisto PT: Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: a comparative study in the rat. J Pharmacol Exp Ther. 2003 Feb;304(2):498-506. [PubMed:12538800 ]
  9. Tai CH, Wu RM: Catechol-O-methyltransferase and Parkinson's disease. Acta Med Okayama. 2002 Feb;56(1):1-6. [PubMed:11873938 ]
  10. Kaakkola S: Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease. Drugs. 2000 Jun;59(6):1233-50. [PubMed:10882160 ]
  11. Ruottinen HM, Rinne UK: COMT inhibition in the treatment of Parkinson's disease. J Neurol. 1998 Nov;245(11 Suppl 3):P25-34. [PubMed:9808337 ]
HMDB0033038Theaflavate BThumbC36H28O15700.5985
700.142820226		Not Available
HMDB0033070Theaflavate A152542-70-6ThumbC43H32O19852.7028
852.153778842		Not Available
HMDB0030569Swertiajaponin6980-25-2ThumbC22H22O11462.4035
462.116211546		Not Available
HMDB0001185S-Adenosylmethionine485-80-3ThumbC15H23N6O5S399.445
399.145063566		Not Available
HMDB0000939S-Adenosylhomocysteine979-92-0ThumbC14H20N6O5S384.411
384.12158847		Not Available
HMDB0037368Quercetin 3-(6''-malonyl-glucoside)96862-01-0ThumbC24H22O15550.4225
550.095870034		Not Available
HMDB0005794Quercetin117-39-5ThumbC15H10O7302.2357
302.042652674		Not Available
HMDB0030624Quercetagitrin548-75-4ThumbC21H20O13480.3757
480.090390726		Not Available
HMDB0000957Pyrocatechol120-80-9ThumbC6H6O2110.1106
110.036779436		Not Available
HMDB0037687Prunus inhibitor b83889-81-0ThumbC30H24O11560.505
560.13186161		Not Available
HMDB0001856Protocatechuic acid99-50-3ThumbC7H6O4154.121
154.026608673		Not Available
HMDB0029251Pinotin A aglyconeThumbC25H19O9463.413
463.102907206		Not Available
HMDB0030806Petunin25846-73-5ThumbC28H33O17641.5514
641.17177463		Not Available
HMDB0038093Petunidin 3-galactoside28500-02-9ThumbC22H23O12479.4108
479.1189512		Not Available
HMDB0003173Petunidin13270-60-5ThumbC16H13O7317.2702
317.06612777		Not Available
HMDB0030802Patuletin519-96-0ThumbC16H12O8332.2617
332.05321736		Not Available
HMDB0030614Orientin28608-75-5ThumbC21H20O11448.3769
448.100561482		Not Available
HMDB0000819Normetanephrine97-31-4ThumbC9H13NO3183.2044
183.089543287		Not Available
HMDB0000216Norepinephrine51-41-2ThumbC8H11NO3169.1778
169.073893223		Not Available
HMDB0037408Neocarlinoside83151-89-7ThumbC26H28O15580.4915
580.142820226		Not Available
HMDB0015272Micafungin235114-32-6ThumbC56H71N9O23S1270.274
1269.438350313
  1. Groll AH, Stergiopoulou T, Roilides E, Walsh TJ: Micafungin: pharmacology, experimental therapeutics and clinical applications. Expert Opin Investig Drugs. 2005 Apr;14(4):489-509. [PubMed:15882123 ]
  2. Wiederhold NP, Lewis JS 2nd: The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Expert Opin Pharmacother. 2007 Jun;8(8):1155-66. [PubMed:17516879 ]
Displaying metabolite protein links 1 - 25 of 94 in total